Page 138 - CW E-Magazine (13-5-2025)

Pharmaceuticals Hydrocarbons

PE INVESTMENT FEEDSTOCK SOURCING

TPG to acquire 35% stake in Schott Poonawalla Trafi gura to supply 2.5-mt of LNG to IOC till 2030

from Serum Institute of India Indian Oil Corporation (IOC) said we aim to see our sales growing by investment in Terra Clean (wholly-owned
that it has signed a term deal with Sin- three folds from current levels and plan subsidiary) to undertake additional
Globa; asset management fi rm, and cartridges for auto-injector pens. Mr. Adar Poonawalla, CEO of Serum gapore-based commodities supplier, to enhance our infrastructure capacity 4.3 gigawatts (GW) renewable energy
TPG, has agreed to acquire a 35% The company also provides regula- Institute of India. “We are excited to Trafi gura, for supplying 2.5-million tonnes accordingly to meet the evolving energy (RE) capacity.
stake in drug containment fi rm Schott tory services and works closely with partner with Schott Pharma and SII and (mt) of liquefi ed natural gas (LNG). needs of the nation.”
Poonawalla from Pune-based Serum CDMOs (Contract Development and build upon Schott Poonawalla’s market “This is further to our communica-
Institute of India (SII). The acquisition Manufacturing Organisations). leadership position as India’s largest Under the deal, Trafi gura will supply Venturing into the natural gas mar- tion dated March 15, 2023, and April
is being led by TPG Growth – TPG’s injectables-focused drug containment LNG to IOC via 27 cargoes spread keting business about two decades ago, 30, 2024, in respect of formation of
middle-market and growth equity TPG said its investment is intended solutions company,” said Mr. Bhushan over from the second half of 2025 IOC has established itself as the sec- a wholly-owned subsidiary in India
platform – with Denmark-based Novo to support the company’s growth Bopardikar, Business Unit Partner at for the next fi ve years. The deal with ond-largest player in imported natural named Terra Clean and equity invest-
Holdings joining as a co-investor. Once ambitions both in India and globally. TPG Growth. the global trader is based on US Henry gas business in India. It has a 5 mt per ment of Rs. 1,303.75-crore in Terra
the deal closes, SII will retain a minority Hub prices, said Mr. A. S. Sahney, annum (mtpa) LNG terminal at Clean for implementation of 1-GW in-
holding in Schott Poonawalla, while “Partnering with TPG marks an The move comes at a time when Chairman, IOC. Kamarajar Port, Ennore, in Tamil stalled capacity of RE project,” it said.
Schott Pharma continues as the con- important step for us. Their expe- pharmaceutical companies are ramping Naidu, which is the fi rst LNG terminal
trolling stakeholder. rience in healthcare investing and up capacity for biologics and complex IOC had a 13 percent share of on the east coast in South India, an The board has also approved
global network make them a strong injectable drugs, with demand for India’s natural gas market in FY24, up untapped natural gas market. additional equity investment of
Schott Poonawalla, a joint venture partner as we scale and explore new high-quality packaging solutions rising from 10 percent in FY23. Rs. 1,086-crore in Terra Clean for
between German speciality glassmaker opportunities. sharply. Green push setting up additional 4.3-GW RE
Schott Pharma and SII – part of the The company in its annual report of In a separate fi ling on the BSE, capacity over and above the already
Cyrus Poonawalla Group – manufac- Our collaboration with Schott Pharma The deal is expected to close in FY24 said, “By the end of the decade, IOC’s Board has approved further approved 1-GW capacity, it added.
tures a wide range of advanced contain- will continue, ensuring supply chain the fi rst half of 2025, subject to regula-
ment and delivery systems including resilience and advancing innovation in tory approvals and customary closing
vials, pre-fi llable syringes, ampoules, vaccine packaging and delivery,” said conditions. TRADE TRENDS
Alembic gets USFDA nod for heart attack prevention India’s crude oil imports from US to surge in April-June

As per Kpler data, India is likely ling, informed, “US crude imports by
India is expected to buy more than
drug 1-million barrels per day (mbpd) from to import around 1,007-kbpd of crude Indian refi ners – particularly public
Alembic Pharmaceuticals said it has and tentative approval for Ticagrelor death, myocardial infarction (MI), and the US during April-June 2025 – a oil from the US during April to June sector entities – are shaped by a mix of
received approval from the US health tablets, 60-mg, Alembic Pharma said stroke in patients with acute coronary record high. this CY, which is higher by 29 percent geopolitical considerations and trade
regulator to market a generic medica- in a statement. syndrome. y-o-y and more than double the imports diversifi cation efforts.
tion for the prevention of heart attack This is in line with India’s stated during Q2 2023.
and stroke. The company’s approved ANDA According to IQVIA, Ticagrelor position to enhance annual energy imports While diplomatic balancing may
is therapeutically equivalent to Astra- tablets (90-mg) have an estimated from the US to $25-bn from $15-bn The US Energy Information Admini- justify one or two cargoes, refi nery
The company has received fi nal Zeneca Pharmaceuticals’ Brilinta market size of $1,062-mn for twelve currently. Both crude oil and liquefi ed stration (EIA) data also points to a economics ultimately drive sustained
approval from the US Food & Drug tablets, 60-mg and 90-mg, it added. months ending March 2025. The 60-mg natural gas (LNG) purchases from the similar dynamic. India imported around buying. Currently, discounted WTI
Administration (USFDA) for its version has an estimated market size US are already at a record high in 2024 942-kbpd during April-June 2024, prices are being used to stimulate Asian
abbreviated new drug application Ticagrelor tablets are indicated to of $242-mn for twelve months ending calendar year (CY). which is 43 percent higher than Q2 2023 demand amid weakening Chinese
(ANDA) for Ticagrelor tablets, 90-mg reduce the risk of cardiovascular (CV) March 2025. and 35 percent higher than Q2 2022. appetite.”
According to global real-time data
USFDA inspection of Zydus’ API unit in Gujarat and analytics provider Kpler, India’s Imports during Q2 2024 are US EIA in its December 2024 Short
crude oil imports from the US rose 17 the highest on record, barring the Term Energy Outlook, said that India
concludes with six observations percent m-o-m and 68 percent y-o-y to COVID-impacted Q2 2021 when emerged as the leading source of growth
roughly 337 thousand barrels per day cargoes touched 1,355-kbpd as prices in global oil consumption in 2024 and
Zydus Lifesciences has informed located at Dabhasa in Gujarat. The none of them were related to data (kbpd) in April – an eight-month high – hit rock bottom. 2025, overtaking China this year. This
that the American health regulator, inspection was conducted from April integrity. The company is confi dent to provisionally. April is the third con- is important considering China’s oil
USFDA, conducted a surveillance 21st to 25th, 2025. “The inspection address the observations expeditiously,” secutive month with in-bound shipments Mr. Sumit Ritolia, Kpler’s Lead consumption outpaced India’s almost
inspection at the group’s API unit concluded with 6 observations and it added. clocking higher volumes. Research Analyst for Refi ning & Mode- every year from 1998 through 2023.

138 Chemical Weekly May 13, 2025 Chemical Weekly May 13, 2025 139

Contents Index to Advertisers Index to Products Advertised